柳化股份(600423.SH):2024年淨利潤3017.53萬元 同比下降58.81%
格隆匯3月20日丨柳化股份(600423.SH)公佈2024年年度報告,2024年,公司緊緊圍繞既定的生產經營計劃,通過抓安全、嚴管理、強質量等措施,保證生產系統實現長週期、穩定、安全、高產、低耗運行,公司去年實施完成的雙氧水稀品裝置6萬噸/年擴產技術升級項目和年產2萬噸雙氧水濃品項目發揮了較好的作用,27.5%雙氧水產量較上年同期增加34.50%,50%雙氧水則很好的起到了調節產品結構的作用,本報告期較好的完成經營業績,實現營業收入16,489.40萬元,同比增長16.20%;實現淨利潤3,017.53萬元,同比下降58.81%,扣非後淨利潤3,367.53萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.